BioCentury
BioCentury is a private, subscription-based biotech industry intelligence platform providing proprietary analysis, curated databases, podcasts, and global networking events for biotech executives, investors, and pharmaceutical companies across North America, Europe, and Asia.
- Company typePrivate
- Founded1992
- HeadquartersSan Mateo, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
What BioCentury does
BioCentury Inc. is a privately held, subscription-based B2B intelligence platform serving the global biotechnology industry, founded in 1992 and headquartered in the San Francisco Bay Area. The company provides proprietary analysis, curated structured data, multimedia content, and global networking events targeting biotech and biopharma C-suite executives, venture capital and investment firms, and large pharmaceutical companies that require decision support on deals, regulatory developments, scientific breakthroughs, and competitive dynamics. Named enterprise customers include Takeda, Lundbeckfonden, and Jazz Pharmaceuticals.
The platform is organized around four pillars: BioCentury Analysis (proprietary reporting on product development, deals and finance, politics/policy/law, and discovery/translation), BCIQ Data (a curated database with company, deal, product, target, financial, and IPO profiles plus the Innovation Distillery of 200-word translational briefs on early-stage research), Events (Grand Rounds U.S. and Europe, China Healthcare Summit, East-West Biopharma Summit, Bio€quity Europe), and Workspace (a customizable portal with saved searches and personalized alerts). Supporting products include the BioCentury This Week podcast, The BioCentury Show webcast, webinars, and co-branded white papers.
Revenue is generated primarily through recurring enterprise subscriptions on annual billing, supplemented by event registration, conference and podcast sponsorship packages, and co-branded content partnerships. Customer acquisition is community-led and event-driven, leveraging a global network spanning North America, Europe (UK, Germany, France, Netherlands, Denmark), and Asia (China, Korea, Singapore, Taiwan, Japan, Australia). Leadership includes co-founder, president & CEO David Flores, CTO David Smiling, and Josh Berlin as Head of Global Business Development, Conferences & China/Asia Strategy.
BioCentury firmographics
Firmographics- Name
- BioCentury
- Legal name
- BioCentury Inc.
- Website
- https://biocentury.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BioCentury is a private, subscription-based biotech industry intelligence platform providing proprietary analysis, curated databases, podcasts, and global networking events for biotech executives, investors, and pharmaceutical companies across North America, Europe, and Asia.
- Ownership category
- akta.pro rank
BioCentury industry classification
Industry- Product category
- Biopharmaceutical Business Intelligence
- NAICS
- Software Publishers (51321)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where BioCentury is headquartered
LocationHeadquarters
- HQ city
- San Mateo
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioCentury business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Subscription Intelligence Platform: BioCentury operates primarily as a subscription-based B2B intelligence platform providing access to biotech industry analysis, databases (BCIQ), and proprietary content. Subscribers include biotech executives, investors, and pharmaceutical company leaders who pay for comprehensive industry intelligence.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Platform subscription with trial available |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels10 records
BioCentury product offering
Product offeringCore offering
BioCentury is a subscription-based business-intelligence platform serving the biopharmaceutical industry. It sells editorial analysis, proprietary datasets (BCIQ), an integrated Workspace product, and industry events that together support drug-development, clinical-research, and pharmaceutical-strategy decision-making for biopharma executives and investors.
Product overview
BioCentury offers a unified biotech industry intelligence platform comprising four core pillars: BioCentury® Analysis (proprietary reporting and commentary on industry trends, deals, and regulatory developments), BioCentury® Data/BCIQ (a curated database with company, deal, product, target, and financial profiles plus the Innovation Distillery for early-stage innovations), BioCentury® Events (global conferences including Grand Rounds, China Healthcare Summit, and Bio€quity Europe), and BioCentury® Workspace (personalized portal with custom feeds and alerts). Supporting content products include podcasts (BioCentury This Week, The BioCentury Show), webinars, white papers, and special reports. The BCIQ database integrates all profile types with direct links to BioCentury analyst insights, providing context alongside structured data.
Differentiator
Problem solved
Functional benefit
Brands
- BCIQ: BioCentury's comprehensive Drug Discovery & Development Database providing structured intelligence across biotech and biopharma, including company profiles, deal profiles, product profiles, target profiles, and financial dashboards.
- BioCentury This Week
- The BioCentury Show
- Innovation Distillery
- BioCentury Workspace
- Grand Rounds
Products and services
- BioCentury Analysis Editorial analysis and reporting on biopharmaceutical drug development, clinical trials, regulatory developments, and industry strategy, targeted at biopharma executives and investors.
- BCIQ Data Proprietary structured datasets covering clinical trials, biopharma deals, financings, and regulatory milestones, designed to support competitive intelligence and pipeline analysis.
- BioCentury Workspace Online research environment that integrates BioCentury editorial analysis with the BCIQ datasets and selected third-party data sources, aimed at biopharma analysts and strategists.
- BioCentury Events Industry conferences and convenings for biopharmaceutical executives and investors, supported through tickets and corporate sponsorships.
Quantifiable outcome
- BioCentury covers global biotech deals with comprehensive enrichment and high accuracy through BCIQ database
- +1 more outcomes
Companies that use BioCentury
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
BioCentury technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioCentury partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered major and core.
- Daejeon TechnoparkmajorBioCentury signed trilateral MOU with Daejeon Technopark and Daejeon Metropolitan Government to establish a channel connecting local Korean biotech companies with global investors and pharmaceutical partners through Biopharma Exchange events.
- Daejeon Metropolitan GovernmentmajorPartnership positions Daejeon as a global biotech investment hub, supported by the Daejeon Bio Startup Hub scheduled for completion in first half of 2027.
- Korea Biotechnology Industry OrganizationcoreBioCentury co-hosted the 5th East-West BioPharma Summit (March 9-11, 2026, Seoul) with Korea BIO, featuring Global IR @JPM investor relations presentations connecting Korean biotechs with global investors.
- Sidley AustinmajorSidley Austin co-hosted the 6th annual Global IR @JPM event with Korea BIO and BioCentury in San Francisco, connecting 17 global investment firms with 10 domestic and overseas biotech corporations.
- Oppenheimer & Co.majorBioCentury and Oppenheimer co-presented the Capital Markets Preview webinar discussing how policy changes impact investor sentiment and biotech market outlook, featuring leading investors and KOLs.
- McKinsey & CompanycoreMcKinsey & Company serves as Insights Partner for multiple BioCentury events including China Healthcare Summit, East-West Biopharma Summit, and produces co-branded white papers on biotech trends, innovation, and market strategies.
- BayHelixcoreBayHelix co-presents the East-West Biopharma Summit and China Healthcare Summit with BioCentury, bringing together global executives for cross-border collaboration and innovation discussion.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
BioCentury competitors and assessment
Company assessmentDirect peers
- Endpoints News: Endpoints News is a biotech-focused digital media outlet covering deals, clinical readouts, and industry leadership. It mirrors BioCentury's editorial mission of fact-based, in-depth biotech reporting for executives and investors, and increasingly competes for advertising/sponsorship dollars.
- Evaluate (Norstella): Evaluate provides pharma and biotech commercial intelligence including consensus forecasts, deal data, and product pipelines. It directly overlaps with BioCentury's BCIQ in deal profiling, product profiles, and financial dashboards, serving the same investor and pharma BD personas.
- Citeline (formerly Pharma Intelligence): Citeline (Informa Pharma Intelligence) is the most direct peer, providing clinical trial intelligence, drug development data, and pharma market intelligence to the same biotech executive and investor audience BioCentury serves. Both companies compete for subscriptions covering deals, pipelines, and competitive intelligence.
- Fierce Biotech (Questex): Fierce Biotech is a long-running biotech trade publication providing news, analysis, and event coverage to pharma and biotech professionals. It competes for the same reader attention and marketing budget as BioCentury's editorial and event franchises.
Broad incumbents
- S&P Global Market Intelligence (Capital IQ Pro): S&P Global Market Intelligence offers biotech financial dashboards, M&A data, and competitive intelligence as part of a broad enterprise platform. It competes with BioCentury's Financial Dashboards and is bundled into multi-domain enterprise contracts that BioCentury cannot match.
- GlobalData: GlobalData is a larger intelligence provider with broad coverage across pharma, healthcare, and consumer industries. It offers biotech deal and pipeline data similar to BCIQ but as part of a wider enterprise portfolio, competing on multi-domain enterprise contracts.
- Informa Pharma Intelligence: Informa Pharma Intelligence is the parent of Citeline and a broader portfolio of pharma intelligence brands (Pink Sheet, Scrip, Medtech Insight). It competes with BioCentury across both editorial coverage and data subscriptions at the enterprise level.
- IQVIA: IQVIA is a global healthcare data and analytics incumbent with deep pharma R&D, clinical trial, and commercial intelligence offerings. While not a direct editorial peer, its biotech intelligence modules compete with BCIQ on the enterprise side.
- PitchBook (Morningstar): PitchBook provides private market intelligence including VC deal data that overlaps with BioCentury's deal profiles. While broader than biotech, it serves the same VC and investor customer base and competes for subscription wallet share.
Emerging players
- Crunchbase: Crunchbase provides company, funding, and deal intelligence with increasing depth in biotech. While broader and less biotech-specialized, it competes at the lower-priced end of the deal intelligence market that overlaps with parts of BCIQ.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
BioCentury social profiles
Digital presenceBioCentury financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioCentury leadership team
Management profileNumber of profiles
Profiles3 records
BioCentury funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioCentury M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioCentury
What does BioCentury do?
BioCentury is a subscription-based business-intelligence platform serving the biopharmaceutical industry. It sells editorial analysis, proprietary datasets (BCIQ), an integrated Workspace product, and industry events that together support drug-development, clinical-research, and pharmaceutical-strategy decision-making for biopharma executives and investors.
Is BioCentury a public or private company?
BioCentury is a private company. It is classified as unknown and is currently operating.
When was BioCentury founded?
BioCentury was founded in 1992. It employs 51 to 100 people.
Where is BioCentury based?
BioCentury is headquartered in San Mateo, United States, in the North America region.
How does BioCentury make money?
One revenue line is on record: subscription Intelligence Platform.
Who are BioCentury's main competitors?
Direct peers on record are Endpoints News, Evaluate (Norstella), Citeline (formerly Pharma Intelligence) and Fierce Biotech (Questex). Broad incumbents are S&P Global Market Intelligence (Capital IQ Pro), GlobalData, Informa Pharma Intelligence, IQVIA and PitchBook (Morningstar). Crunchbase is listed as an emerging player.
Does BioCentury have an API?
No public API is recorded for BioCentury.
What industry is BioCentury in?
BioCentury's product category is Biopharmaceutical Business Intelligence. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 51321 and its SIC code is 7372.